NEW YORK, Feb 14 (Reuters) - A U.S. appeals court reversed part of a ruling in favor of Watson Pharamaceutials over Cephalon in patent lawsuit over the cancer drug Fendora.
The U.S. Court of Appeals for the Federal Circuit upheld, however, the lower court's ruling that Watson did not infringe Cephalon's patents.
(Reporting by Erin Geiger Smith; Editing by Leslie Gevirtz) Keywords: WATSON APPEALS
(firstname.lastname@example.org)(+1 646 223 6143)(Reuters Messaging: email@example.com@reuters.net)
Copyright Thomson Reuters 2013. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.